Clinical Trial Update: Fingolimod in Endovascular Treatment of Ischemic Stroke [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on fingolimod as an adjunct in endovascular treatment for ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Fingolimod (fingolimod)

Snippet

Sponsor: Ning Wang, MD., PhD. | Conditions: Stroke Inflammation | Phase 2 | Status: UNKNOWN